Syra Health Return on Equity (ROE) Growth & History (SYRA)

Syra Health's return on equity was −36.02% for fiscal 2025.

View full Syra Health company overview

Syra Health annual return on equity history

Syra Health annual return on equity

Fiscal yearPeriod endedReturn on equityChange (percentage points)
20252025-12-31−36.02%+73.07 pp
20242024-12-31−109.09%+15.33 pp
20232023-12-31−124.42%

Syra Health return on equity trends

Between the periods ended 2023-12-31 and 2025-12-31, Syra Health's return on equity increased from −124.42% to −36.02%, a change of +88.40 percentage points. The latest reported quarter, Q2 2026, shows 10.02%.

About the metric

What return on equity (ROE) means

Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.

Calculation and source

How return on equity is calculated

TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Syra Health source filings ↗

Community posts

It’s quiet here.

No posts about SYRA yet. Start the conversation.

Write the first post